Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 11.84 | 13.48 | 14.41 | 285.67 | 625.26 |
| Expenses | |||||
| Material consumed | - | - | - | 70.88 | 156.07 |
| Manufacturing expenses | - | - | - | 48.14 | 85.85 |
| Personnel expenses | 17.46 | 15.29 | 14.60 | 33.85 | 58.74 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 31.02 | 28.74 | 35.08 | 84.10 | 91.69 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 48.49 | 44.03 | 49.68 | 236.97 | 392.34 |
| Operating profit | -36.64 | -30.55 | -35.26 | 48.70 | 232.92 |
| Other recurring income | 5.32 | 7.75 | 14.04 | 27.25 | 23.27 |
| Adjusted PBDIT | -31.33 | -22.79 | -21.23 | 75.95 | 256.19 |
| Financial expenses | 0.53 | 0.82 | 0.54 | 1.90 | 4.61 |
| Depreciation | 4.39 | 4.35 | 4.17 | 10.79 | 21.31 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | -36.25 | -27.95 | -25.94 | 63.25 | 230.27 |
| Tax charges | - | -5.32 | -12.18 | 24.06 | 71.84 |
| Adjusted PAT | - | -22.63 | -13.75 | 39.19 | 158.43 |
| Non recurring items | -0.15 | -0.31 | -0.30 | -0.14 | -0.28 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | -36.40 | -22.94 | -14.05 | 39.06 | 158.15 |
| Earnigs before appropriation | 161.43 | 197.83 | 220.77 | 554.54 | 553.47 |
| Equity dividend | - | - | - | - | 15.21 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | 3.89 |
| Retained earnings | 161.43 | 197.83 | 220.77 | 554.54 | 534.38 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis